Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

GITRL RNA-transfected Autologous Dendritic Cell Vaccine

Known as: GITRL RNA DC, GITRL RNA-transfected Autologous DC 
An autologous dendritic cell (DC) cancer vaccine with potential immunostimulatory activity. GITRL RNA-transfected autologous DC vaccine is prepared… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
BackgroundGlucocorticoid-induced TNFR-related protein (TNFRSF18, GITR, CD357), expressed by T cells, and its ligand (TNFSF18… Expand
Is this relevant?
2017
2017
BackgroundThe expansion of antigen-specific CD8 T cells is important in generating an effective and long-lasting immune response… Expand
Is this relevant?
2016
2016
Adipose-derived mesenchymal stem cells (ASCs) are readily available multipotent mesenchymal progenitor cells and have become an… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2015
2015
Glukokortikoidle induklenen tumor nekrozis faktor reseptoru (GITR) ve ligandi GITRL, tumor nekrozis faktor (TNF) ailesi… Expand
Is this relevant?
2015
2015
............................................................................................................................... II ACKNOWLEDGEMENTS ..................................................................................................... IV TABLE OF CONTENTS ........................................................................................................... V LIST OF TABLES ................................................................................................................. VIII LIST OF FIGURES .................................................................................................................. IX LIST OF APPEDICES ............................................................................................................. XI LIST OF PUBLICATIONS AND PRESENTATIONS ........................................................ XII ABBREVIATIONS .................................................................................................................. XV CHAPTER 1: INTRODUCTION .............................................................................................. 2 PART I: THE CO-STIMULATORY TNFRSF MEMBER GITR .......................................................... 2 1.1. AN INTRODUCTION TO T CELL CO-STIMULATION AND THE TNFR FAMILY MEMBER GITR .. 2 1.2. EXPRESSION, REGULATION, AND STRUCTURAL FEATURES OF GITR AND GITRL ................ 3 1.3. INTRACELLULAR SIGNALING BY GITR ................................................................................. 4 1.4. STRUCTURE-FUNCTIONAL IMPLICATIONS OF GITR-GITRL INTERACTION ........................... 8 1.5. EFFECTS OF GITR-GITRL INTERACTIONS ON INNATE CELL SUBSETS .................................. 8 1.5.1. GITR-GITRL in innate inflammatory responses in vitro ............................................. 8 1.5.2. GITR-GITRL in leukocyte adhesion and migration .................................................... 9 1.5.3. Reverse signaling through GITRL in innate cells ..................................................... 10 1.5.4. Effect of GITR on NK and NKT cells ......................................................................... 11 1.6. THE ROLE OF GITR-GITRL ON B CELLS ........................................................................... 11 1.7. SIGNALING BY GITR ON REGULATORY AND CONVENTIONAL CD4 AND CD8 T CELLS. ..... 12 1.7.1. GITR co-stimulation of murine T cells ...................................................................... 12 1.7.2. Cross-regulation between GITR and other co-stimulatory molecules on T cells ...... 14 1.7.3. GITR co-stimulation of human T cells ....................................................................... 14 1.8. CELL-TYPE SPECIFIC EFFECTS OF GITR IN CANCER ............................................................ 15 1.8.1. GITR-targeted therapies for cancer .......................................................................... 15 1.8.2. Mechanisms of enhanced tumour immunity with GITR-targeted therapies .............. 16 1.8.3. GITR-GITRL in cancer immune evasion: modulating of NK and tumour cells ........ 17 1.9. GITR-GITRL IN INFLAMMATION, TRANSPLANTATION, ALLERGY, AND AUTOIMMUNITY ... 18 1.9.1. GITR-GITRL in inflammatory diseases ..................................................................... 18 1.9.2. GITR-GITRL in allergy ............................................................................................. 19 1.9.3. GITR-GITRL in models of colitis and autoimmunity ................................................. 19 1.9.4. Autoimmune models with Treg-extrinsic effects of GITR-GITRL ............................. 22 1.9.5. GITR-GITRL in tissue transplant models .................................................................. 23 1.9.6. Correlating GITR and GITRL expression in human autoimmune diseases .............. 24 
  • figure 1-1
  • figure 1-2
  • table 1-1
  • figure 1-3
  • figure 1-4
Is this relevant?
2013
2013
Bronchial asthma is a global respiratory allergic disease, with the rising incidence of bronchial asthma in children. It has… Expand
Is this relevant?
Review
2010
Review
2010
The ability of the tumor necrosis factor receptor (TNFR) family member GITR to modulate immune responses has been the subject of… Expand
  • figure 1
Is this relevant?
Highly Cited
2009
Highly Cited
2009
The reciprocal interaction of tumor cells with the immune system is influenced by various members of the tumor necrosis factor… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2006
2006
The glucocorticoid‐induced TNF‐related receptor ligand (GITRL) was previously shown to be constitutively expressed at low levels… Expand
Is this relevant?
2005
2005
The role of CD95 ligand (FasL/Apo‐1L)‐expressing tumors in immunosuppression or immunopotentiation is controversial. CD95L… Expand
Is this relevant?